Depemokimab cuts exacerbation rate in eosinophilic asthma
by Elana GotkineFor patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a studypublishedonline Sept. 9 in the
Updated on: October 01,2024
0

Depemokimab cuts exacerbation rate in eosinophilic asthma
by Elana GotkineFor patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a studypublishedonline Sept. 9 in the
Updated on:October 01,2024
0
